Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Co-Expression of DevR and DevRN-Aph Proteins Is Associated with Hypoxic Adaptation Defect and Virulence Attenuation of Mycobacterium tuberculosis

  • Shyamasree De Majumdar ,

    Contributed equally to this work with: Shyamasree De Majumdar, Deepak Sharma

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Deepak Sharma ,

    Contributed equally to this work with: Shyamasree De Majumdar, Deepak Sharma

    Current address: National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Atul Vashist,

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Kohinoor Kaur,

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Neetu Kumra Taneja,

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Santosh Chauhan,

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

  • Vijay K. Challu,

    Affiliation National Tuberculosis Institute, Bangalore, India

  • V. D. Ramanathan,

    Affiliation Department of Pathology, Tuberculosis Research Centre, Chennai, India

  • V. Balasangameshwara,

    Affiliation National Tuberculosis Institute, Bangalore, India

  • Prahlad Kumar,

    Affiliation National Tuberculosis Institute, Bangalore, India

  • Jaya Sivaswami Tyagi

    Affiliation Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India

Co-Expression of DevR and DevRN-Aph Proteins Is Associated with Hypoxic Adaptation Defect and Virulence Attenuation of Mycobacterium tuberculosis

  • Shyamasree De Majumdar, 
  • Deepak Sharma, 
  • Atul Vashist, 
  • Kohinoor Kaur, 
  • Neetu Kumra Taneja, 
  • Santosh Chauhan, 
  • Vijay K. Challu, 
  • V. D. Ramanathan, 
  • V. Balasangameshwara, 
  • Prahlad Kumar



The DevR response regulator is implicated in both hypoxic adaptation and virulence of Mycobacterium tuberculosis (M. tb). DevR regulon genes are powerfully induced in vivo implicating them in bacterial adaptation to host control strategies. A better understanding of DevR function will illumine the way for new strategies to control and treat tuberculosis.

Methodology/Principal Findings

Towards this objective, we used a combination of genetic, microbiological, biochemical, cell biological tools and a guinea pig virulence assay to compare the hypoxic adaptation and virulence properties of two novel M. tb strains, namely, a devR disruption mutant, Mut1, that expresses C-terminal truncated N-terminal domain of DevR (DevRNTD) as a fusion protein with AphI (DevRN-Kan), and its complemented strain, Comp1, that expresses intact DevR along with DevRN-Kan. Comp1 bacteria exhibit a defect in DevR-mediated phosphosignalling, hypoxic induction of HspX and also hypoxic survival. In addition, we find that Comp1 is attenuated in virulence in guinea pigs and shows decreased infectivity of THP-1 cells. While Mut1 bacilli are also defective in hypoxic adaptation and early growth in spleen, they exhibit an overall virulence comparable to that of wild-type bacteria.


The hypoxic defect of Comp1 is associated to a defect in DevR expression level. The demonstrated repression of DevR function by DevRN-Kan suggests that such a knockdown approach could be useful for evaluating the activity of DevRS and other two-component signaling pathways. Further investigation is necessary to elucidate the mechanism underlying Comp1 attenuation.


Mycobacterium tuberculosis (M. tb) is a versatile intracellular pathogen that has the ability to either cause active disease or produce a persistent latent infection. Tubercle bacilli exhibit dramatically contrasting phenotypes under these two conditions; during frank disease they are virulent, multiply actively and are susceptible to anti-tubercular therapy while during latent infection they display the property of non-replicative persistence, remain dormant and are quite resistant to anti-tubercular drug regimens. Therefore, an understanding of the dormant bacterial state is vital in order to devise strategies targeted towards their control and elimination. The interaction of M. tb with the host is likely to be dynamic and complex and to involve multiple phases of adaptation and regulatory networks. M. tb genome sequencing has revealed the presence of a panoply of potential regulatory molecules that comprise of transcriptional regulators, sigma factors and signaling systems including two-component systems (TCS) and eukaryotic-like serine threonine protein kinases/phosphatases [1]. All of these are likely to play a dynamic role in bacterial adaptation to the changing environmental conditions within the host.

Bacterial TCS are involved in the control of a wide variety of physiological processes ranging from nutrient uptake to virulence. TCS of M. tb have been intensely studied by many laboratories and as expected, several of these systems are responsible for bacterial adaptation within the host [2], [3]. One of the best characterized TCS of M. tb is devRS (also called dosRS). devR (Rv3133c or dosR) was identified as a differentially expressed gene in virulent M. tb H37Rv [4], [5] and it encodes DevR which is activated by transfer of phosphosignal from DevS and/or Rv2027c/DosT [6][8]. It is directly involved in the hypoxia-induced dormancy response [9][11] and also in virulence [12][15]. Moreover, DevR and its target genes are highly expressed in animals and cell infection models which suggests that bacteria rely on them for adaptation in vivo [16][20].

DevR is a classical response regulator which contains a N-terminal phosphorylation domain and a C-terminal DNA binding domain [5]. Phosphorylation of DevR is essential for the activation of its DNA binding function, its autoinduction and the induction of DevR regulon genes expression [21][23]. A novel devR mutant strain, Mut1, was generated serendipitously in our laboratory by an in-frame insertion of a promoterless kanamycin resistance cassette into the devR gene at an unique PpuMI site which results in the expression of C-terminal truncated DevR as a DevRNTD-AphI fusion protein (DevRN-Kan). The fusion protein confers kanamycin resistance to the mutant bacterium and enabled its original selection [13]. Its complemented strain, Comp1, expresses intact DevR from its native 327 bp upstream region along with DevRN-Kan fusion protein [13]. In the present study, we studied the properties of guinea pig-passaged Mut1 and Comp1 bacteria alongside wild-type H37Rv (WT) bacteria. We find that Mut1 bacilli exhibit a defect in hypoxic adaptation and early growth within spleen but exhibited overall virulence nearly comparable to WT bacilli. Interestingly, in Comp1 bacteria, DevRN-Kan competes for the activating phosphosignal resulting in a defective hypoxia adaptive response. We also find that Comp1 is attenuated in virulence. The potential implications and possible application of these findings are discussed.


DevRN-Kan Inhibits HspX Induction in Comp1 Bacteria

hspX is a DevR-regulated gene and its expression is a reliable marker of DevR regulon expression. HspX expression was strongly induced in hypoxic WT cultures (Fig. 1, lanes 1–2) in contrast to the lack of expression in Mut1 bacteria. Surprisingly however, HspX was only weakly expressed in Comp1 bacteria (that expresses both DevRN-Kan and full-length DevR proteins) under similar conditions. To correlate with this defect, DevR expression was assessed; while it was induced in hypoxic WT cultures (Fig. 1, lanes 1–2), its level declined in Comp1 bacteria (Fig. 1, lanes 3–4). Furthermore, DevR level was consistently lower relative to DevRN-Kan (∼55% and ∼20% under aerobic and hypoxic conditions respectively, a representative blot is shown in Fig. 1, lanes 3–4).

Figure 1. Effect of DevRN-Kan and full-length DevR co-expression on DevR regulon gene expression.

M. tb lysates were electrophoresed and subjected to immunoblot analysis using polyclonal antibodies to HspX (top panel), DevR (middle panel) and SigA (bottom panel). Lanes 1, 3, 5, 7, 9, 11 and 13 represent aerobic culture and lanes 2, 4, 6, 8, 10, 12 and 14 represent 5 days standing hypoxic cultures. Anti-HspX immunoblots were developed for longer periods to visualize HspX in Comp1 bacterial lysates. Representative blots from 2 to 4 independent cultures are shown.

The Expression Defect in Comp1 Is Ascribed to Inhibition of Signaling by DevRN-Kan

The skewed protein ratios (possibly due to differences in promoter strength) suggest that DevRN-Kan may interfere with intact DevR function in Comp1 bacteria. This hypothesis was tested by assessing HspX expression in Comp2 strain that was generated by introducing pDSDevR into a complete devR deletion mutant strain (Tables 1 and 2). HspX induction was restored in Comp2 (Fig. 1, lanes 5–6), indicating that the hypoxic expression defect in Comp1 was due to DevRN-Kan-mediated inhibition. Towards understanding the underlying basis of this defect, the promoters expressing intact DevR and DevRN-Kan proteins were compared since in Comp1 bacteria, full-length DevR is expressed from the complementing plasmid through its upstream promoter (as in pdevR-2) while DevRN-Kan is expressed from its natural genomic location (as in pOperon-2). From the GFP reporter activity it is evident that pOperon-2 displays both aerobic and DevR-dependent inducible expression under hypoxia while pdevR-2 shows constitutive and moderate activity that is independent of DevR (Fig. 2). Considering the results of immunoblotting and reporter assays, the observed decline in DevR protein level during hypoxia in Comp1 bacteria is likely to be a consequence of a defect in expression (since DevR ectopic expression from a constitutive promoter is not sensitive to induction during hypoxia). By contrast, DevRN-Kan levels maybe stabilized as a fusion protein and/or due to DevR expression from the inducible promoter (since Comp1 bacteria synthesize DevR, albeit at low levels).

Figure 2. Comparison of promoter activity using GFP reporter assay.

GFP fluorescence in M. tb WT and Mut1 cultures carrying operon (pOperon-2) and devR (pdevR-2) promoter constructs under aerobic and hypoxic conditions.

The inhibitor function of DevRN-Kan was confirmed in two additional M. tb strains (Table 2). In Comp3 bacteria (generated in H37Rv background and expressing DevRN-Kan and WT DevR proteins, each from the native inducible promoter), HspX expression was induced (Fig. 1, lanes 7–8), indicating that DevRN-Kan inhibitory activity is overcome in the presence of WT DevR levels. However, HspX induction was not rescued in Comp4 bacteria (generated in a complete devR deletion strain that produced a skewed ratio of DevRN-Kan and full-length DevR proteins), akin to Comp1 bacteria (Fig. 1, lanes 9–10). Note that although DevRN-Kan was expressed at an elevated level from its ectopic location in Comp3 and Comp4 strains vs. from its native location in Comp1 (Fig. 1), HspX expression was consistently restored in Comp3 bacteria but not in Comp4 bacteria. Likewise, absence of HspX induction in Comp4 but not Comp2 bacteria (both in complete devR deletion background) is attributed to the presence of DevRN-Kan in the former (Fig. 1). These results establish that the hypoxic defect of Comp1 in terms of HspX expression is associated to a defect in DevR expression level.

We next asked whether DevRN-Kan competed with DevR for the activating phosphosignal in Comp1 bacteria by reconstituting the phosphosignaling reaction in vitro. Briefly, DevRN-Kan coding sequences (exactly as expressed in Mut1 bacilli) were cloned, the overexpressed protein was purified and used with full-length DevR in a DevS∼P-driven competition assay (Fig. 3). The phosphosignal was transferred to DevR and DevRN-Kan inhibitor with approximately similar efficiency when they were present at equimolar concentrations. Importantly, the signal was diverted majorly to the inhibitor at higher concentrations of DevRN-Kan, which mimics the protein ratios in vivo, indicating that preferential phosphorylation of DevRN-Kan is likely to occur in vivo. Moreover, in a phosphosignaling competition assay performed with DevRN protein (without the kanamycin resistance cassette), similar results were obtained (not shown), thereby attributing the inhibition to DevRN in the fusion protein.

Figure 3. DevRN-Kan competes efficiently with full-length DevR for phosphosignal from DevS.

Reaction mixtures containing purified DevS∼P (5 µM) plus DevRN-Kan (0.83 to 30 µM) and full-length DevR (5 µM) proteins were incubated at 25°C for 2 minutes. Samples were analyzed by 15% SDS-PAGE and subjected to phosphorimaging (top panel) and Coomassie blue staining (bottom panel).

All these findings, namely, (a) efficient diversion of phosphosignal to DevRN-Kan in vitro, (b) skewed DevRN-Kan: DevR protein ratio in vivo resulting in diversion of the phosphosignal to the former and, (c) defective HspX induction in Comp1 and Comp4 bacteria, conclusively establish that DevRN-Kan inhibits DevR signaling.

Comp1 Bacteria Are Defective in Hypoxic Survival

As DevR plays a crucial role in the mycobacterial adaptive response to hypoxia, we evaluated the survival properties of Comp1 bacteria under hypoxia (Fig. 4). Hypoxic viability was sustained in WT bacilli and on day 50, ∼105% of the bacteria remained viable (relative to maximum CFU on day 10). By contrast, the hypoxic survival defect in Mut1 bacilli was evident from day 5 (the earliest time point when bacteria were sampled) and only ∼2% of the initial bacterial load (maximum CFU) were viable on day 50. If we compare initial and final number of bacteria, there is little difference in hypoxic viability between Comp1 and WT strains. However, under hypoxic conditions, Comp1 grew more rapidly than WT bacteria during the first 10 days and thereafter its viability was not sustained and on day 50, approximately 5% of the bacteria were viable relative to maximum CFU observed on day 10. All the strains grew at similar rates and exhibited similar viability under aerobic conditions. The hypoxia survival defect of Comp1 bacteria is attributed to an insufficient level of activated DevR. Another possible underlying reason for the defect in Comp1 bacteria is that expression of DevR from the natural genomic location and from complementing plasmids is very different and these differences may affect other proteins involved in the two-component system signaling in an unknown manner.

Figure 4. Survival of M. tuberculosis strains cultured in vitro.

WT, Mut1 and Comp1 strains were grown under hypoxic (A) and aerobic (B) conditions for upto 50 days in Dubos Tween Albumin medium as described. The mean CFU ± SD determined from three independent cultures is shown as % survival with respect to number of bacteria on day zero. ▪, WT; □, Mut1 and ▿, Comp1.

M. tuberculosis Comp1 Strain Is Attenuated in Guinea Pigs

Passaged Mut1, Comp1 and WT bacteria were tested in the guinea pig virulence model [24], [25]. At 6 weeks, a nearly similar number of lesions were visually scored for both the WT and mutant strains. By contrast, fewer lesions were visually scored in the Comp1 group (P<0.05 in comparison to WT and Mut1 groups, Table 3). The spleens of WT and mutant-infected groups were also significantly enlarged in comparison to Comp1 group of animals (Table 3 and Fig. 5A). The extent of lung and liver granuloma (P<0.05 in comparison to WT group) and lung CFU were lower in the Comp1 group (Fig. 5B and Table 3) and spleen CFU was lower in both mutant and complemented groups (P<0.05 in comparison to WT, Fig. 5B).

Figure 5. Virulence of passaged M. tuberculosis strains in guinea pigs.

(A) Pictorial representation of lungs and spleens. (B) CFU in lungs and spleens are expressed as mean ± SD. *, ** represent P<0.05 in comparison to WT and Mut1, respectively.

To evaluate disease progression, a second infection of 13 weeks was performed. An increase in visually scored tubercles was noted in all the groups; however, once again the number of visually scored lesions was lower in the Comp1 group (P<0.05, Table 3). Progressive splenic enlargement was noted at 13 weeks in WT and Mut1 groups but not in the Comp1 group (Table 3). CFUs in lungs and spleens also increased at 13 weeks for all the strains. Although fewer bacteria were recovered from lungs and spleen of Mut1-infected animals at both 6 and 13 weeks of infection, with the exception of a significant reduction in spleen CFU at 6 weeks (Fig. 5B), the differences were not significant compared to the WT group (Fig. 5B). However, a significant growth defect of Comp1 bacilli persisted at 13 weeks in both organs (Fig. 5B). The extent of organ granuloma correlated quite well with bacterial CFU and visual scores (Table 3). In qualitative terms, granulomas in liver were composed essentially of lymphocytes, macrophages and large numbers of epithelioid cells. In the lung, epithelioid cells were rare and the granuloma consisted mainly of lymphocytes and macrophages (not shown). There was very little necrosis in both the organs. Overall, the results of the two experiments are consistent with an attenuation of Comp1 bacteria (P<0.05 compared to WT) and a modest lowering of virulence for Mut1 bacteria that was not significant.

Reduced Infectivity of Comp1 Bacilli in THP-1 Infection Model

The strains were next assessed in the THP-1 cell infection model to determine whether Comp1 bacteria possessed an intracellular survival defect (Fig. 6). Passaged and laboratory cultured organisms of all the strains exhibited quite similar intracellular survival and growth properties over a 7-day period (Fig. 6). However, Comp1 bacteria displayed a reduced ability to infect THP-1 cells in comparison to the WT and Mut1 strains (Fig. 6 insets). For the passaged strains, the infectivity rate of the WT and Mut1 strains was 9.8% and 8.5% compared to 4.3% for Comp1 bacteria. Similar observations were made with the laboratory cultured strains; only 4.3% infection was observed with Comp1 bacteria compared to 7.4% and 6.7% for WT and Mut1 strains, respectively. The macrophage infection assay performed at a higher m.o.i (1 bacterium per 10 macrophages) further confirmed the decreased infectivity of Comp1 organisms (not shown).

Figure 6. Intracellular survival of M. tuberculosis strains.

THP-1 cells were infected with various strains (A, passaged and B, laboratory cultured strains) at a m.o.i of 1∶50 (bacterium: macrophage) and the number of intracellular viable bacteria was determined over 7 days. Results are given as the mean ± SD of 3 independent experiments. (Inset) Infectivity of the three strains in THP-1 cells as determined by 2 separate experiments. *, ** P<0.05 indicate significant differences in infectivity between Comp1 vs. WT and Mut1, respectively. •, WT; ○, Mut1 and ▴, Comp1.

Animal Passaged Mut1 Bacilli Multiply Preferentially in Lungs

In a guinea pig virulence assay performed previously, Mut1 bacilli were observed to be attenuated in terms of visually observable lesions and spleen CFUs [13]. However, Mut1 bacterial attenuation was not observed in the present study. The difference between the two studies is that the previous study was performed with Mut1 bacteria that had been repeatedly cultured in vitro during the generation of the mutant strain, whereas the present one was carried out with guinea pig-passaged bacteria. Since repeated in vitro culture of pathogenic bacteria can result in their attenuation [26], we compared animal passaged and laboratory cultured bacteria in a 6 weeks side-by-side guinea pig virulence assay to determine whether repeated laboratory culture was the underlying reason for the observed attenuation of Mut1 bacteria. Interestingly, spleen CFUs in Mut1 bacilli group were significantly lower relative to WT CFUs in both passaged and laboratory cultured bacilli (Fig. S1) and these results were consistent with our previous observations [13]. Observable lesions, liver granulomas and spleen weight ratios were also significantly lower in laboratory cultured Mut1 bacilli infected group (Table S1). This was also consistent with previous observations [13] indicating that overall pathology was decreased by laboratory passaging (P<0.05, Table S1). By contrast, passaged, and not laboratory cultured, Mut1 bacteria exhibited prolific multiplication in lung accompanied by a decrease in splenic CFU load suggesting that laboratory cultured bacilli exhibited a lung-specific defect (P<0.05, Fig. S1).


In this study a devR disruption mutant strain, Mut1, and its complemented strain, Comp1, were assessed for their hypoxia adaptability and virulence properties. The Comp1 strain is novel in that it is defective in the hypoxic response. This defect is explained by skewed expression of DevRN-Kan vs. intact DevR protein and an associated skewing of phosphosignaling, which likely results in insufficient availability of activated DevR.

A key finding of this study is that Comp1 bacteria are attenuated. We exclude the possibility of attenuation due to an intrinsic growth defect since Comp1 bacteria multiply normally in broth cultures and within infected THP-1 cells. However, lower infectivity of THP-1 cells suggests a scenario wherein Comp1 bacteria could be gradually cleared over multiple cycles of infection and result in significantly lower bacterial loads. Since bacteria disseminate from the site of injection in the thigh to various organs in this virulence assay [24], an infectivity and/dissemination defect could also contribute to its attenuation. However, differences in infecting dose as a possible reason for differences in virulence are ruled out since an approximately equal number of viable organisms of each strain were injected subcutaneously per animal.

Passaged Mut1-infected guinea pigs contained significantly lower spleen bacterial loads at 6 weeks and this was consistent with our previous observations [13]. Although lung CFUs were also lower in Mut1 vs. WT-infected animals, the difference was not significant. Therefore we conclude that passaged Mut1 bacilli are overall nearly as virulent as WT organisms. In contrast, the Comp1 strain was attenuated by all parameters (organ inflammation, histology, visually observable lesions and organ CFUs). Studies with various devR or dosR mutant and complemented strains have reported virulence phenotypes ranging from attenuation to hypervirulence and these variations have been attributed to differences in strain construction and the use of different models [12][15]. Our experiments indicate that animal passaging restores the ability of Mut1 bacilli to multiply in guinea pig lungs suggesting that a decreased capacity of laboratory cultured organisms to establish a productive lung infection is a key aspect of attenuation that could have occurred by repeated in vitro culturing during Mut1 construction. It was recently suggested that the variable results of various animal studies could be explained by differences in both host and infecting dose [15]. Our study provides evidence that the mode of bacterial propagation also significantly influences the virulence phenotype.

Except for the present study performed with a disruption mutant, all other investigations were performed with deletion mutant strains. The strains also vary in the expression of the co-transcribed devS gene; Mut1 expresses DevS [7], unlike a dosR mutant [15]. Since DevRS/DosT comprise the DevR signaling pathway and wild-type levels of dosT transcripts were detected in Mut1 and Comp1 bacilli (data not shown), a paucity of signaling through the kinases is unlikely to occur in Mut1 or Comp1 strains. Therefore we attribute the hypoxia adaptation defect to the disruption of devR function alone and not that of the kinases. We have established in the present study that DevRN is the active inhibitor species in the DevRN-Kan fusion protein. Moreover, the kanamycin resistance cassette is routinely used in genetic analysis and is not known to confer any abnormal phenotype to M. tb. Therefore, our results establish DevRN-Kan as a signaling inhibitor of the DevR-mediated hypoxia response and we exclude an ‘unnatural’ function for the fusion protein in this response. However, the effect of DevRN-Kan expression per se on other aspects of bacterial physiology including virulence awaits further investigation.

Importantly, the attenuated phenotype exhibited by Comp1 bacteria was stable and not modulated by animal passaging. Further investigation is necessary to understand the mechanism underlying attenuation of the Comp1 strain. However, the demonstrated repression of WT DevR function by DevRN-Kan signaling inhibitor suggests the possibility that such a knockdown approach that intercepts bacterial signaling could be useful for studying and perhaps for modulating the activity and function of other M. tb signaling pathways.

Materials and Methods

The plasmids and strains used in this study are described in Tables 1 and 2, respectively.

Construction of pAVdevRN–Kan

The devR gene was disrupted by in-frame insertion of a kanamycin resistance cassette (kan) from pGP1–2 (kind gift from Dr. S. Tabor, USA) at an unique PpuMI site. DevRN-Kan fusion protein-coding DNA sequence was cloned downstream of the native operon promoter described earlier [21] to generate pAVdevRN -Kan.

Preparation of Passaged Bacilli

All experiments were performed with guinea pig-passaged M. tb WT, Mut1 and Comp1 strains unless mentioned otherwise. For passaging, −70°C frozen stocks of laboratory cultured bacilli were thawed, resuspended in PBS and ∼5×106 CFU were injected subcutaneously into guinea pigs as described [13]. Bacilli were recovered from guinea pig spleens at 6 weeks post infection by plating on Middlebrook (MB) 7H11 agar with OADC. Bacterial scrapings were cultured in 7H9 medium containing Albumin Dextrose Complex (ADC) and stored frozen at −80°C for further use.

Bacterial Culture

Frozen passaged bacterial stocks were sub cultured twice or thrice to logarithmic phase (A595∼0.4) prior to viability and expression analysis.

Expression Analysis

Various logarithmic phase M. tb cultures were diluted to A595 of 0.025 and grown with shaking to an A595 of 0.3. A culture aliquot was immediately harvested by centrifugation (aerobic culture). For hypoxic cultures, 10 ml aliquots of aerobic cultures were dispensed into 50 ml screw-capped tubes and kept standing for 5 days. Lysates were prepared as described [27] from two to four independent cultures at each condition. Aliquots containing 10 to 15 µg protein were subjected to immunoblotting using rabbit polyclonal antisera as described [19]. Anti-SigA antibody was a generous gift from Dr. T.S. Balganesh (AstraZeneca, Bangalore). Densitometric analysis was performed using Quantity One software (Biorad, USA). The signal intensities derived from SigA in each lysate were used to normalize the signal intensities from DevR and DevRN-Kan.

GFP Reporter Assay

GFP reporter activity of pOperon-2 and pdevR-2 constructs was assessed under aerobic and hypoxic conditions as described earlier [28]. Briefly, the M. tb strains were subcultured twice to mid-logarithmic phase and then 3.3 ml aliquots (A595 = 0.1) were dispensed in 5 ml Vacutainer tubes (BD) which were kept standing (hypoxic conditions). GFP fluorescence was measured at the specified time points.

In Vitro Phosphotransfer Competition Assays

Full length DevS (DevS578) was purified as described earlier [29]. Full-length DevR was overexpressed and purified from E. coli C43 harbouring pAVDevR by standard techniques. DevRN -Kan fusion protein was purified from E. coli carrying pKKNKan by standard techniques. DevS578 (5 µM) was autophosphorylated using 5 µCi γ - 32P-ATP (approximately 3800–4000 Ci/mmole, BRIT, Mumbai, India) in a 20 µl reaction containing 50 mM Tris, pH 8.0, 50 mM KCl, 25 mM MgCl2 and 50 µM ATP at 25°C for 60 min as described [7]. DevS578∼P was added to a mixture of full-length DevR (5 µM) and DevRN-Kan (at concentrations ranging from 0.83 to 30 µM to attain molar ratios of 1∶6 to 6∶1 for DevR∶DevRN-Kan, respectively) and incubated for 2 min at room temperature. Samples were electrophoresed through a 15% SDS-PAGE and the gel was subjected to phosphorimaging.

Assessment of Viability of M. tuberculosis Strains In Vitro

M. tb cultures were diluted to A595 of 0.005 and 10 ml aliquots were dispensed in 50 ml tubes and grown either with shaking at 220 rpm (aerobic setup) or kept standing in 15 ml tubes (hypoxic setup). Cultures were sampled once only from separate tubes dedicated for each time point of the hypoxia set up. Bacterial CFU at defined time points was estimated by plating serial dilutions in duplicate on MB 7H11 agar containing ADC and incubating the plates at 37°C for 6 weeks.

Guinea Pig Virulence Assay

Approval was taken from the Institutional Animal Ethics Committee, NTI, Bangalore prior to guinea pig experiments. Guinea pigs were infected by subcutaneous route with passaged M. tb strains in phosphate buffered saline (approx. 5×106 viable organisms per animal) for 6 weeks and 13 weeks (6–10 animals per group) as described [13]. The virulence assay in guinea pigs was performed as described [13], [24], [25]. In this model, bacteria spread to the lungs and spleen from the site of injection (thigh). Briefly, at the time of sacrifice, internal organs were examined for visually scorable lesions in spleen, liver, lung, inoculation site and its draining lymph nodes as described [24]. Lungs and spleens were transferred to selective Kirchner's liquid medium for CFU determination as described [13]. The spleens and right lower lobes of lungs were individually homogenized in dedicated homogenizers and serial dilutions were plated in duplicate on MB 7H11 agar containing OADC and also on LJ slopes. The colonies were counted after 6 weeks of incubation at 37°C. Portions of lung and liver were fixed in 10% formalin and processed for histopathological analysis by staining with haematoxylin and eosin as described previously [30]. Laboratory cultured strains were also assessed in the 6 weeks virulence assay (10 animals per group). The statistical significance of the differences between the various strains for different parameters was determined using the Mann-Whitney test.

THP-1 Infection Assays

The inocula for infection were prepared by culturing M. tb strains with shaking to A595∼0.6 in Dubos Tween Albumin. THP-1 cell line was maintained in RPMI 1640 medium supplemented with 10% fetal calf serum and monolayers were prepared and infected as described [31]. Briefly, THP-1 cells were seeded at 0.25×106 cells per well in 24-well tissue culture plates and were differentiated by the addition of phorbol 12-myristate acetate (100 nM) for 24 h. The monolayers were infected with M. tb strains at a low m.o.i. (1 bacterium per 50 macrophages) for 20 h, washed with incomplete RPMI 1640. Fresh complete RPMI 1640 was added to each well and the plates were incubated at 37°C for upto 7 days. Intracellular viable bacteria on day 1, 4 and 7 postinfection were assessed by lysis of the monolayers in 0.025% SDS, followed by plating serial dilutions as described above. Infectivity is expressed as a fraction of the number of bacteria internalized on day 1 to the total number of bacilli added. Significance was determined by one-way ANOVA followed by post-hoc analysis using Bonferroni correction.

Supporting Information

Figure S1.

Bacterial recovery (Mean plus/minus SD) from guinea pigs infected for 6 weeks with passaged or laboratory cultured M. tb strains. *, * *, P<0.05 in comparison to WT and Mut1, respectively. #, P<0.05 between the passaged and the laboratory cultured strains.

(0.18 MB TIF)


We thank Dr. H.K. Prasad for his valuable suggestions on THP-1 infection experiments. N.K.T. is thankful to A. Singhal for his help in setting up the THP-1 infection experiments. The expert technical assistance of Sanjay, S. Nambirajan, K. Chandran and the staff of NTI animal house in particular B.R. Thimmegowda and Tajunissa is also appreciated. M. Kalaivani and Shahima are sincerely acknowledged for their enthusiastic help in statistical analysis of the data. We also acknowledge the facilities of the Biotechnology Information System (BTIS) of the Department of Biotechnology at AIIMS.

Author Contributions

Conceived and designed the experiments: SDM DS AV KK NKT SC VKC VDR VB PK JST. Performed the experiments: SDM DS AV KK NKT SC VKC VDR. Analyzed the data: SDM DS AV KK NKT SC VKC VDR JST. Contributed reagents/materials/analysis tools: SDM AV KK SC VDR. Wrote the paper: SDM DS AV KK NKT SC VDR JST.


  1. 1. Cole ST, Barrell BG (1998) Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp 217: 160–172; discussion 172–167.
  2. 2. Tyagi JS, Sharma D (2004) Signal transduction systems of mycobacteria with special reference to M. tuberculosis. Curr Sci 86: 93–102.
  3. 3. Av-Gay Y, Deretic V (2005) Two-component systems, protein kinases and signal transduction in Mycobacterium tuberculosis. In: Cole ST, Eisenach KD, McMurray DN, Jacobs WR Jr, editors. Tuberculosis and the tubercle bacillus. Washington DC: ASM Press. pp. 359–367.
  4. 4. Kinger AK, Tyagi JS (1993) Identification and cloning of genes differentially expressed in the virulent strain of Mycobacterium tuberculosis. Gene 131: 113–117.
  5. 5. Dasgupta N, Kapur V, Singh KK, Das TK, Sachdeva S, et al. (2000) Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuber Lung Dis 80: 141–159.
  6. 6. Roberts DM, Liao RP, Wisedchaisri G, Hol WG, Sherman DR (2004) Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem 279: 23082–23087.
  7. 7. Saini DK, Malhotra V, Dey D, Pant N, Das TK, et al. (2004a) DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology 150: 865–875.
  8. 8. Saini DK, Malhotra V, Tyagi JS (2004b) Cross talk between DevS sensor kinase homologue, Rv2027c, and DevR response regulator of Mycobacterium tuberculosis. FEBS Lett 565: 75–80.
  9. 9. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, et al. (2001) Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc Natl Acad Sci U S A 98: 7534–7539.
  10. 10. Boon C, Dick T (2002) Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 184: 6760–6767.
  11. 11. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. (2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48: 833–843.
  12. 12. Parish T, Smith DA, Kendall S, Casali N, Bancroft GJ, et al. (2003) Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect Immun 71: 1134–1140.
  13. 13. Malhotra V, Sharma D, Ramanathan VD, Shakila H, Saini DK, et al. (2004) Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol Lett 231: 237–245.
  14. 14. Rustad TR, Harrell MI, Liao R, Sherman DR (2008) The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 3: e1502.
  15. 15. Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, et al. (2009) Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect Immun 77: 1230–1237.
  16. 16. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ (2003) Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A 100: 241–246.
  17. 17. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198: 705–713.
  18. 18. Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, et al. (2004) Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J Exp Med 200: 647–657.
  19. 19. Sharma D, Bose A, Shakila H, Das TK, Tyagi JS, et al. (2006) Expression of mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and Acr, within lung granulomas throughout guinea pig infection. FEMS Immunol Med Microbiol 48: 329–336.
  20. 20. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, et al. (2008) Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS One 3: e1403.
  21. 21. Chauhan S, Tyagi JS (2008) Cooperative binding of phosphorylated DevR to upstream sites is necessary and sufficient for activation of the Rv3134c-devRS operon in Mycobacterium tuberculosis: implication in the induction of DevR target genes. J Bacteriol 190: 4301–4312.
  22. 22. Chauhan S, Tyagi JS (2008) Interaction of DevR with multiple binding sites synergistically activates divergent transcription of narK2-Rv1738 genes in Mycobacterium tuberculosis. J Bacteriol 190: 5394–5403.
  23. 23. Chauhan S, Tyagi JS (2009) Powerful induction of divergent tgs1-Rv3131 genes in Mycobacterium tuberculosis is mediated by DevR interaction with a high-affinity site and an adjacent cryptic low-affinity site. J Bacteriol 191: 6075–6081.
  24. 24. Mitchison DA, Wallace JG, Bhatia AL, Selkon JB, Subbaiah TV, et al. (1960) A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tubercle 41: 1–22.
  25. 25. Mitchison DA, Bhatia AL, Radhakrishna S, Selkon JB, Subbaiah TV, et al. (1961) The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test. Bull World Health Organ 25: 285–312.
  26. 26. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, et al. (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520–1523.
  27. 27. Rodrigue S, Brodeur J, Jacques PE, Gervais AL, Brzezinski R, et al. (2007) Identification of mycobacterial σ factor binding sites by chromatin immunoprecipitation assays. J Bacteriol 189: 1505–1513.
  28. 28. Bagchi G, Chauhan S, Sharma D, Tyagi JS (2005) Transcription and autoregulation of the Rv3134c-devR-devS operon of Mycobacterium tuberculosis. Microbiology 151: 4045–4053.
  29. 29. Saini DK, Pant N, Das TK, Tyagi JS (2002) Cloning, overexpression, purification, and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis. Protein Expr Purif 25: 203–208.
  30. 30. Ramanathan VD, Jawahar MS, Paramasivan CN, Rajaram K, Chandrasekar K, et al. (1999) A histological spectrum of host responses in tuberculous lymphadenitis. Indian J Med Res 109: 212–220.
  31. 31. Lukey PT, Hooker EU (2001) Macrophage virulence assays. In: Parish T, Stoker NG, editors. Mycobacterium tuberculosis Protocols. Totowa, NJ: Humana Press. pp. 271–280.
  32. 32. Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, et al. (2006) Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. J Bacteriol 188: 1856–1865.